Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M, Matveev V, Piulats JM, Zucca LE, Karyakin O, Kimura G, Matsubara N, Nahas WC, Nolè F, Rosenbaum E, Heidenreich A, Kakehi Y, Zhang A, Krissel H, Teufel M, Shen J, Wagner V, Higano C. Smith M, et al. Among authors: nahas wc. Lancet Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6. Lancet Oncol. 2019. PMID: 30738780 Clinical Trial.
Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
Lestingi JFP, Guglielmetti GB, Trinh QD, Coelho RF, Pontes J Jr, Bastos DA, Cordeiro MD, Sarkis AS, Faraj SF, Mitre AI, Srougi M, Nahas WC. Lestingi JFP, et al. Among authors: nahas wc. Eur Urol. 2021 May;79(5):595-604. doi: 10.1016/j.eururo.2020.11.040. Epub 2020 Dec 5. Eur Urol. 2021. PMID: 33293077 Clinical Trial.
Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries.
Monteiro FSM, Schutz FA, Morbeck IAP, Bastos DA, de Padua FV, Costa LAGA, Maia MC, Rinck JA Jr, Zequi SC, da Trindade KM, Alfer W Jr, Nahas WC, Dos Santos LV, Ferrigno R, da Rosa DAR, Sade JP, Orlandi FJ, de Oliveira FNG, Soares A. Monteiro FSM, et al. Among authors: nahas wc. JCO Glob Oncol. 2021 Apr;7:538-544. doi: 10.1200/GO.20.00508. JCO Glob Oncol. 2021. PMID: 33856897 Free PMC article.
Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group.
Ilario EN, Bastos DA, Guglielmetti GB, Murta CB, Cardili L, Cordeiro MD, Junior JP, Coelho RF, Nahas WC. Ilario EN, et al. Among authors: nahas wc. Clin Genitourin Cancer. 2023 Feb;21(1):43-54. doi: 10.1016/j.clgc.2022.10.009. Epub 2022 Oct 22. Clin Genitourin Cancer. 2023. PMID: 36428171 Clinical Trial.
MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
Pimenta RC, Viana NI, Amaral GQ, Park R, Morais DR, Pontes J Jr, Guimaraes VR, Camargo JA, Leite KR, Nahas WC, Srougi M, Reis ST. Pimenta RC, et al. Among authors: nahas wc. Tumour Biol. 2018 Nov;40(11):1010428318803011. doi: 10.1177/1010428318803011. Tumour Biol. 2018. PMID: 30400755 Free article.
285 results